MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Pfizer

Fermé

SecteurSoins de santé

25.68 -2.21

Résumé

Variation du prix de l'action

24h

Actuel

Min

25.63

Max

26.47

Chiffres clés

By Trading Economics

Revenu

-45M

2.9B

Ventes

938M

15B

P/E

Moyenne du Secteur

13.984

37.257

BPA

0.78

Rendement du dividende

6.21

Marge bénéficiaire

19.982

Employés

81,000

EBITDA

266M

5.3B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+8.6% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

6.21%

2.94%

Prochains Résultats

4 nov. 2025

Date du Prochain Dividende

1 déc. 2025

Date du Prochain Détachement de Dividende

7 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

16B

150B

Ouverture précédente

27.89

Clôture précédente

25.68

Sentiment de l'Actualité

By Acuity

40%

60%

150 / 371 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Pfizer Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

1 oct. 2025, 08:54 UTC

Principaux Mouvements du Marché

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

30 sept. 2025, 15:07 UTC

Principaux Mouvements du Marché

Pfizer Shares Rise After WSJ Reports Company Will Lower Drug Costs

22 sept. 2025, 14:54 UTC

Acquisitions, Fusions, Rachats

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- 2nd Update

22 sept. 2025, 11:51 UTC

Acquisitions, Fusions, Rachats

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 sept. 2025, 11:09 UTC

Acquisitions, Fusions, Rachats

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion

22 sept. 2025, 10:13 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Metsera Shares Leap Premarket on Report of Takeover by Pfizer

22 sept. 2025, 07:42 UTC

Acquisitions, Fusions, Rachats

Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources

5 août 2025, 11:34 UTC

Résultats

Pfizer Boosts 2025 Adjusted EPS Outlook Following 2Q Gains

22 sept. 2025, 15:17 UTC

Acquisitions, Fusions, Rachats

Pfizer Jumps Back into the Weight-Loss Race With $4.9B Acquisition -- Barrons.com

22 sept. 2025, 13:43 UTC

Acquisitions, Fusions, Rachats

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 sept. 2025, 11:26 UTC

Acquisitions, Fusions, Rachats

These Stocks Are Moving the Most Today: Fox, Coinbase, Metsera, Pfizer, Kenvue, Anywhere Real Estate, Premier, and More -- Barrons.com

22 sept. 2025, 11:26 UTC

Acquisitions, Fusions, Rachats

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- WSJ

22 sept. 2025, 10:48 UTC

Acquisitions, Fusions, Rachats

Pfizer: Metsera Deal Adds Four Clinical-Stage Incretin, Amylin Programs to Pipeline >PFE MTSR

22 sept. 2025, 10:47 UTC

Acquisitions, Fusions, Rachats

Pfizer: Metsera Deal Includes Contingent Value Rights Worth Up to Additional $22.50/Share >PFE MTSR

22 sept. 2025, 10:46 UTC

Acquisitions, Fusions, Rachats

Pfizer: Metsera Deal Has Initial Enterprise Value of $4.9 Billion >PFE MTSR

22 sept. 2025, 10:45 UTC

Acquisitions, Fusions, Rachats

Pfizer to Pay Initial $47.50/Share for Metsera >PFE MTSR

22 sept. 2025, 10:45 UTC

Acquisitions, Fusions, Rachats

Pfizer to Acquire Metsera and Its Next-Generation Obesity Portfolio >PFE MTSR

22 sept. 2025, 09:12 UTC

Actions en Tendance

Stocks to Watch Monday: Nippon Steel, Porsche, Infosys, Metsera -- WSJ

5 août 2025, 20:44 UTC

Résultats

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 août 2025, 18:20 UTC

Résultats

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 août 2025, 18:17 UTC

Résultats

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 août 2025, 16:04 UTC

Market Talk

Pfizer's New Tax Rate Helps Boost Adj EPS Outlook -- Market Talk

5 août 2025, 15:25 UTC

Résultats

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 août 2025, 13:56 UTC

Résultats

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 août 2025, 11:43 UTC

Résultats

Pfizer Stock Pops as Earnings Smash Expectations. Guidance Hiked in Face of Tariffs. -- Barrons.com

5 août 2025, 11:27 UTC

Résultats

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 août 2025, 10:57 UTC

Résultats

Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. -- Barrons.com

5 août 2025, 10:55 UTC

Résultats

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 août 2025, 10:53 UTC

Résultats

Pfizer Boosts 2025 Profit Estimate In A Sign Of 'Confidence' -- MarketWatch

5 août 2025, 10:51 UTC

Résultats

Pfizer: On Track to Deliver About $7.2B Overall Cost Savings From Cost-Improvement Initiatives b/ End of 2027 >PFE

Comparaison

Variation de prix

Pfizer prévision

Objectif de Prix

By TipRanks

8.6% hausse

Prévisions sur 12 Mois

Moyen 28.53 USD  8.6%

Haut 34 USD

Bas 24 USD

Basé sur 17 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

17 ratings

4

Achat

12

Maintien

1

Vente

Score Technique

By Trading Central

22.855 / 23.85Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

150 / 371Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat